Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000 1

Yakugaku Zasshi

Volumn 126, Issue 8, 2006, Pages 657-664

  Vijaya Kumar, Sengodan Gurusamy ^a   Mishra, Dina Nath ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Dissolution enhancement; Meloxicam; Solid dispersion; Solubility

Indexed keywords

MACROGOL 6000; MELOXICAM;

ARTICLE; CONTENT ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG MIXTURE; DRUG SOLUBILITY; DRUG SYNTHESIS; EVAPORATION; HYDROGEN BOND; IN VITRO STUDY; INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; STRUCTURE ACTIVITY RELATION; X RAY DIFFRACTION;

ADJUVANTS, PHARMACEUTIC; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; HYDROGEN BONDING; POLYETHYLENE GLYCOLS; SOLUBILITY; THIAZINES; THIAZOLES; WATER;

EID: 33746827353     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.657     Document Type: Article

References (42)

1. This study was presented at the 6th CRS International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems, February 18-19, 2005, Mumbai, India.
2. Engelhardt G., Homma D., Schlegal K., Utzmann R., Schnitzler C., Inflamm. Res., 44, 423-433 (1995).
3. Craig D. Q. M., Int. J. Pharm., 32, 131-144 (2002).
4. Chiou W. L., Riegelman S., J. Pharm. Sci., 60, 1281-1302 (1971).
5. Leuner C., Dressman J., Eur. J. Pharm. Biopharm., 50, 47-60 (2000).
6. Serajuddin A. T. M., J. Pharm. Sci., 88, 1058-1066 (1999).
7. Craig D. Q. M., Drug Dev. Ind. Pharm., 16, 2501-2527 (1990).
8. Lloyd G. R., Craig D. Q. M., Smith A., J. Pharm. Sci., 86, 991-996 (1997).
9. Zerrouk N., Chemtob C., Arnaud P., Toscani S., Dugue J., Int. J. Pharm., 225, 49-62 (2001).
10. Vijaya Kumar S. G., Mishra D. N., Indian Drugs, 43, 117-121 (2006).
11. Chowdary K. P. R., Hymavathi R., Indian J. Pharm. Sci., 63, 150-154 (2001).
12. Nath B. S., ShivaKumar H.N., Indian J. Pharm. Sci., 62, 129-132 (2000).
13. Baboota S., Agarwal S. P., Indian J. Pharm. Sci., 64, 408-411 (2002).
14. Gowthamarajan K., Kulkarni G. T., Venkateswaran G., Samanta M. K., Suresh B., Indian J. Pharm. Sci., 64, 525-528 (2002).
15. Naidu N. B., Choudary K. P. R., Murthy K. V. R., Satyanarana V., Hayman A. R., Becket G., J. Pharm. Biomed. Anal., 35, 75-86 (2004).
16. Vijaya Kumar S. G., Mishra D. N., Yakugaku Zasshi, 126, 93-97 (2006).
17. El-Miligi M. F., El-Nabarawi M. A., Kholief A. M., El-Halim S. A., Bull. Fac. Pharm. (Cario Univ.), 41, 143-160 (2003).
18. Seedher N., Bhatia S., AAPs Pharm. Scitech., 4, Article 33 (2003).
19. Higuchi T., Connors K. A., "Phase Solubility Techniques, Advances in Analytical Chemistry and Instrumentation," Vol. 4, ed. by Reilly C. N., Interscience, New York, 1965, pp. 117-212.
20. Mura P., Manderioli A., Bramanti G., Caccarelli L., Drug Dev. Ind. Pharm., 22, 909-916 (1996).
21. Guyot M., Awaz F. F., Bildet J., Bonini F., Laquany A. M., Int. J. Pharm., 123, 53-63 (1995).
22. Ambike A. A., Mahadik K. R., Paradkar A., Int. J. Pharm., 282, 151-162 (2004).
23. Mura P., Faucci M. T., Manderioli A., Bramanti G.,Ceccareili L., J. Pharm. Biomed. Anal., 18, 151-163 (1998).
24. Veiga M. D., Bernad M. J., Escobar C., Int. J. Pharm., 89, 119-124 (1993).
25. Veiga M. D., Diaz P., Gines J. M., Rabasco A. M., Pharmazie., 49, 906-909 (1994).
26. Bettinetti G. P., Bruni G.,Giordano F., Mura P., Drug Dev. Ind. Pharm., 20, 2215-2225 (1994).
27. Mura P., Faucci M. T., Manderioli A., Bramanti G., Parrini P., Drug Dev. Ind. Pharm., 25, 257-264 (1999).
28. Craig D. Q., Newton J. M., Int. J. Pharm., 74, 43-48 (1991).
29. Sjokvist E., Nystrom C., Alden M., Int. J. Pharm., 69, 53-62 (1991).
30. Marin M. T. M., Margarit M. V. B., Martin J. D. R., Ars Pharm., 43, 73-82 (2002).
31. Khan G. M., Jaiabi Z., Drug Dev. Ind. Pharm., 24, 455-462 (1998).
32. Weuts I., Kempen D., Verreck G., Decorte A., Heymans K., Peeters J., Breuster M., Mooter G. V. D., Eur. J. Pharm. Biopharm., 59, 119-126 (2005).
33. Heo M. Y., Pio Z. Z., Kim T. W., Cao Q. R., Kim A., Lee B. J., Arch. Pharm. Res., 28, 604-611 (2005).
34. Tang L., Khan S. U., Muhammad N. A., Pharm. Dev. Tech., 6, 531-540 (2001).
35. Ford J. L., Pharm. Acta Helv., 61, 69-88 (1986).
36. Liu C., Desai K. G., Pharm. Dev. Tech., 10, 467-477 (2005).
37. Khan K. A., J. Pharm. Pharmacol., 27, 48-49 (1975).
38. Najib N. M., Suleiman M. S., Int. J. Pharm., 51, 225-232 (1989).
39. Chan K. L. A., Kazarian S. G., Molecular Pharmaceutics, 4, 331-335 (2004).
40. Sekiguchi K., Obi N., Ueda Y., Chem. Pharm. Bull., 12, 134-144 (1964).
41. Jafari M. R., Danti A. G., Ahmed I., Int. J. Pharm., 48, 207-215 (1988).
42. Lloyd G. R., Craig D. Q. M., Smith A., Eur. J. Pharm. Biopharm., 48, 59-65 (1998).